This website uses cookies. By continuing you are agreeing to our privacy policy.

Clinical Trials

Ascent

Institution:

AstraZeneca

Type:

Individual Site

Purpose:

Aclidinium Bromide (Tudorza) which is FDA approved for the maintenance bronchodilator treatment of COPD, including chronic bronchitis and emphysema. Its is administered as a dry powder taken vi an inhaler.

Dates:

February 29, 2016 - February 28, 2019

Disease:

COPD

Register:

http://www.activmedresearch.com/

Contact:

Karina Rosario
978-655-7155
[email protected]

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.